Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Adrenoleukodystrophy

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Adrenoleukodystrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bataillard, M; Christmann, D; Dietemann, JL; Kurtz, D; Romero, C1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Adrenoleukodystrophy

ArticleYear
Adrenoleukodystrophy. Value of contrast-enhanced MR imaging.
    Journal of neuroradiology = Journal de neuroradiologie, 1990, Volume: 17, Issue:4

    Topics: Adrenoleukodystrophy; Child; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Iodine; Magnetic Resonance Imaging; Male; Organometallic Compounds; Radiographic Image Enhancement; Tomography, X-Ray Computed

1990